About

Roy Jung is an associate in the Intellectual Property Practice Group in the firm's Washington, D.C. office. Roy’s practice focuses on intellectual property litigation.

Latest Post

In Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. No. 2022-1889, __ F.4th ____ (Fed. Cir. Nov. 6, 2023), the case addresses whether a district court needs to consider the extrinsic evidence when the intrinsic record does not sufficiently render the term non-ambiguous.

Continue Reading Federal Circuit Opines on Whether Intrinsic Record Alone is Sufficient to Inform Claim Construction

About

Roy Jung is an associate in the Intellectual Property Practice Group in the firm's Washington, D.C. office. Roy’s practice focuses on intellectual property litigation.

Subscribe: Subscribe via RSS